A molecular staging model for accurately dating the endometrial biopsy

Direct reprogramming of human fibroblasts to expandable induced dopaminergic neuronal progenitors for Parkinson’s disease therapy

C99R mutation in IRF4 drives a novel gain of function binding and gene upregulation in classical Hodgkin lymphoma

Non-conventional β-catenin activity is essential for Notch1-driven T-cell leukemia

CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation

The miR-497~195 cluster suppresses cell cycle regulators and in vivo leukemia growth in B-cell precursor Acute Lymphoblastic Leukemia

Expression profile and Histone H3 K4, K9, K27, K36 tri-methylation occupancy through the whole genome between control and AMPK knockdown Hep3B cells

Transcriptome analysis of collagen VI-related muscular dystrophy muscle biopsies

Transcriptome (Affymetrix arrays) and Methylome of HepG2 cells uninfected (Cont) or infected with the pathogen Listeria monocytogenes (Inf)

SY-1365, a covalent, first in-class CDK7 inhibitor for cancer treatment

Key Super Enhancers Drive Tumor-Suppressing Transcription Feedback Programs in Mature B Cell Cancers

Comparative Transcriptomics on cellular reactions to short-term hypergravity

Expression data from Sarcoma Tumors expressing the EWSR1-CREB fusions

Molecular alterations induced by Yersinia pestis, dengue virus and Staphylococcus enterotoxin B under the background of battlefield-like stress

RA-MAP: mapping molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

SUMOylation regulates the protein network and chromatin accessibility at glucocorticoid receptor-binding sites

PATZ1-knockdown expression array and PATZ1 ChIP-seq in HepG2 cells

Molecular mechanism of EPC1-PHF1 fusion protein

Selective lymphoma cell killing by a PRC2 small molecule inhibitor

Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified meduloblastoma